Medscape September 7, 2024
Manuela Callari

VIENNA — At the European Respiratory Society (ERS) 2024 Congress, experts discussed the benefits and risks of artificial intelligence (AI) in medicine and explored ethical implications and practical challenges.

With over 600 AI-enabled medical devices registered with the US Food and Drug Administration since 2020, AI is rapidly pervading healthcare systems. But like any other medical device, AI tools must be thoroughly assessed and follow strict regulations.

Joshua Hatherley, PhD, a postdoctoral fellow at the School of Philosophy and History of Ideas at Aarhus University in Denmark, said the traditional bioethical principles — autonomy, beneficence, nonmaleficence, and justice — remain a crucial framework for assessing ethics regarding the use of AI tools in medicine. However, he said the emerging fifth...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), Conferences / Podcast, Medical Devices, Provider, Technology, Trends
Related Articles:
OpenAI’s GPT-5 Model Reportedly Behind Schedule With Uncertain Future
10 AI Predictions For 2025
Three Practical Reasons To Consider AI Agents For Your Organization
Dexcom Adds Generative AI Platform to Its Over-the-Counter CGM
My Medical AI Holiday Wish List

Share This Article